The Glimpse Group, In Partnership with Montefiore Einstein, Unveils Groundbreaking VR Study for Teen Mental Health

Rhea-AI Summary

The Glimpse Group (NASDAQ:VRAR), in collaboration with Montefiore Einstein, has revealed initial results from a groundbreaking study exploring the use of Virtual Reality (VR) in teen mental health therapy. The study, conducted through Glimpse's subsidiary Foretell Reality, utilized multi-user virtual environments to facilitate art-making sessions for teenagers in outpatient psychiatric treatment.

Led by Dr. Jenny Seham under IRB protocols, the pilot study demonstrated significant improvements in emotional expression, anxiety reduction, and peer connection among participating teens. The program leverages Foretell Reality's Immersive software platform to create safe spaces for therapeutic engagement through creative expression and peer interaction.

Positive

• Study shows positive results in emotional expression and anxiety reduction for teen mental health treatment
• Successfully demonstrates practical application of VR technology in healthcare
• Partnership with major healthcare institution Montefiore Einstein validates technology

Negative

• None.

Innovative program marks a significant step forward in using cutting-edge Immersive technology to enhance therapeutic practices

NEW YORK, NY / ACCESS Newswire / September 24, 2025 / The Glimpse Group, Inc. ("Glimpse") (NASDAQ:VRAR), a diversified Immersive Technology platform company providing enterprise-focused Immersive Technology, Spatial Computing and Artificial Intelligence ("AI") driven software and services, along with its Immersive software company Foretell Reality and in collaboration with Montefiore Einstein, announced the initial results of a study to assess the feasibility and acceptability of VR Art making with peers for teens in outpatient psychiatric treatment.

This innovative program, led by Dr. Jenny Seham and conducted under strict IRB protocols, marks a significant step forward in using cutting-edge immersive technology to enhance therapeutic practices.

The pilot study explored how VR can facilitate group and solo art engagement sessions for teenagers facing mental health challenges. Using Foretell Reality's Immersive software platform, participants entered multi-user virtual environments to express themselves creatively and connect with peers in ways traditional therapy often struggles to achieve. Early findings from the study reveal significant improvements in emotional expression, anxiety reduction, and peer connection among participants.

Dr. Jenny Seham of Montefiore Einstein's Department of Psychiatry and Behavioral Sciences, commented: "This study demonstrates the potential for VR to revolutionize how we approach mental health care for teens. By combining art and technology, we've created a safe space for emotional healing and connection."

D.J. Smith, Glimpse's Chief Creative Officer, commented: "It was an honor to work with Montefiore Einstein on this exciting project and the results again validate the transformative therapeutic potential for our VR platform."

About Montefiore Einstein

Montefiore Einstein is a leader in innovative healthcare solutions, dedicated to improving lives through cutting-edge research, compassionate care, and community engagement. This project was made possible via the sponsorship of the Fine Art Program and Collection at Montefiore Einstein, in collaboration with the Department of Psychiatry and Behavioral Sciences; https://montefioreeinstein.org/

About The Glimpse Group, Inc.

The Glimpse Group (NASDAQ: VRAR) is a diversified Immersive technology platform company, providing enterprise-focused Immersive Technology, Spatial Computing and AI driven software & services. Glimpse's unique business model builds scale and a robust ecosystem, while simultaneously providing investors an opportunity to invest directly into this emerging industry via a diversified platform. For more information on The Glimpse Group, please visit www.theglimpsegroup.com

Safe Harbor Statement

This press release does not constitute an offer to sell or a solicitation of offers to buy any securities of any entity. This press release may contain certain forward-looking statements based on our current expectations, forecasts and assumptions that involve risks and uncertainties. Forward-looking statements, if provided, are based on information available to the Company as of the date hereof. Our actual results may differ materially from those stated or implied in such forward-looking statements, due to risks and uncertainties associated with our business. Forward-looking statements, if provided, include statements regarding our expectations, beliefs, intentions, or strategies regarding the future and can be identified by forward-looking words such as "anticipate," "believe," "view," "could," "estimate," "expect," "intend," "may," "should," and "would" or similar words. All forecasts, if provided, are based on information available at this time and management expects that internal projections and expectations may change over time. In addition, any forecasts, if provided, are entirely on management's best estimate of our future financial performance given our current contracts, current backlog of opportunities and conversations with new and existing customers about our products and services. We assume no obligation to update the information included in this press release, whether as a result of new information, future events or otherwise.

Glimpse Contacts:

Maydan Rothblum
CFO & COO
The Glimpse Group, Inc.
917-292-2685
maydan@theglimpsegroup.com

SOURCE: The Glimpse Group, Inc.

View the original press release on ACCESS Newswire

FAQ

What are the key findings of The Glimpse Group's (VRAR) VR mental health study?

The study showed significant improvements in emotional expression, anxiety reduction, and peer connection among teenagers in outpatient psychiatric treatment using VR art-making sessions.

How is The Glimpse Group (VRAR) implementing VR technology in mental health treatment?

Through its subsidiary Foretell Reality, Glimpse is providing multi-user virtual environments where teens can participate in group and solo art engagement sessions as part of their psychiatric treatment.

Who is partnering with The Glimpse Group (VRAR) on the VR mental health study?

The Glimpse Group is partnering with Montefiore Einstein, with the study being led by Dr. Jenny Seham from Montefiore Einstein's Department of Psychiatry and Behavioral Sciences.

What is the purpose of The Glimpse Group's (VRAR) VR therapy platform?

The platform aims to create a safe space for emotional healing and connection by combining art and technology, offering new therapeutic approaches for teenagers facing mental health challenges.